CDC Report: Obesity-related diseases account for nearly 10% of medical spending in the U.S.

According to data recently released by the U.S. Centers for Disease Control and Prevention, obesity-related diseases account for nearly 10 percent of all medical spending in the United States or an estimated $147 billion a year.
U.S. obesity rates rose 37 percent between 1998 and 2006, driving an 89 percent increase in spending on treatments for [...]

Different Perspectives on Funding Innovation – Europe vs. USA

US Health and Human Services Secretary Michael Leavitt recently spoke at a conference in Paris regarding the importance of pharmaceutical innovation.  The following article demonstrates two different perspectives on funding innovation — essentially market forces vs. government price fixing.
US Health Sec warns Europe of “world without innovation”
Government price-fixing of new medicines is “the road to [...]